Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2024-11-06 Earnings Release
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 6, 2024, by CVS Health Corporation. It specifically states in Item 2.02 that it is furnishing a press release announcing results for the three months ended September 30, 2024. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as an exhibit. The length of the document is 3692 characters, which is relatively short and consistent with a current report announcing earnings results rather than the full earnings release document. According to the rules, an initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). Since this is a Form 8-K announcing quarterly results and including a press release, it fits the Earnings Release category rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K).
2024-11-06 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-10-24 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the appointment of a new President and CEO, the departure of the previous CEO, and related board changes. It also references a press release with preliminary financial results but does not contain detailed financial statements or comprehensive financial analysis. The primary focus is on management changes and related disclosures. Therefore, this document fits best under the category of Board/Management Information (MANG). The document length (8300 characters) and detailed description of executive appointments and departures support this classification. It is not an earnings release, annual report, or other financial report type, nor is it a regulatory filing of a different nature.
2024-10-18 English
PRIMARY DOCUMENT
Director's Dealing
2024-09-19 English
PRIMARY DOCUMENT
Director's Dealing
2024-09-03 English
Regulatory Filings 2024
Regulatory Filings
2024-08-09 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.